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Abstract: Benign lymph node inclusions are commonly encountered during surgery for gynecologic neoplasms and 
are potential mimics of metastatic tumor. The presence of mesothelial cell inclusions in pelvic lymph nodes is 
extremely rare. We report the clinicopathologic features of 10 patients with ovarian tumors and mesothelial cell 
inclusions detected in the sinuses of pelvic and paraaortic lymph nodes. All patients had concurrent massive ascites 
and mesothelial cell hyperplasia at the time of lymph node dissection. Histologically, nodal mesothelial cells were 
identified predominantly within the subcapsular, trabecular and medullary sinuses. Moreover, intra- and extranodal 
lymphatics also contained mesothelial cells, confirming their mode of lymphatic transport to nodal sinuses. This 
finding, together with mesothelial cell hyperplasia and massive ascites suggest that mesothelial cells derive from 
reactive serosal mesothelium and are dislodged into draining lymphatics. This study indicated the pathogenic sig-
nificance of the lymphatic transport mechanism. Nodal mesothelial cell inclusions should be distinguished from 
metastatic tumor to avoid inaccurate staging in a patient with a known tumor or the false negative diagnosis of an 
occult primary tumor. Recognition of this entity by immunohistochemical evaluation in addition to routinely stained 
sections is important to prevent a diagnosis of metastatic carcinoma or malignant mesothelioma.
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Introduction
A large number of lymph node inclusions have 
been described in a variety of anatomical sites. 
They are usually epithelial and only rarely non-
epithelial. They can give rise to an errorneous 
diagnosis of metastasis. In particular, the stag-
ing operation has recently become a frequent 
procedure in the management of female repro-
ductive tract tumors, and involves pelvic and 
para-aortic lymph node dissection, inspection 
of the peritoneal surface, multiple biopsies and 
the resection of suspicious lesions. The occa-
sional presence of benign inclusions in the 
resected specimens can mimic metastatic 
malignancy and lead to a diagnostic error. It is 
therefore necessary to be adequately informed 
about these inclusions, including their anatom-
ic sites, histologic characteristics and their 
association with a tumor or an inflammatory 
process. 
Benign inclusions of the lymph nodes include 
nevus cells, decidua, thyroid follicles, salivary 
gland tissue, breast tissue, squamous epitheli-
um, Mullerian-type epithelium and mesothelial 
cells [1-4]. Mullerian-type epithelium in pelvic 
and para-aortic lymph nodes is commonly 
found in women [1]. Inclusions of mesothelial 
cells in the nodal sinuses reportedly occur 
mostly within mediastinal lymph nodes, and 
occasionally within cervical and abdominal 
lymph nodes [5-19]. On the other hand, local-
ization of these inclusions in pelvic or para-aor-
tic lymph nodes is an exceedingly rare event; to 
the best of our knowledge, only 5 cases have 
been previously reported [5, 14, 20].
We recently encountered 10 cases of mesothe-
lial cell inclusions in pelvic and/or para-aortic 
lymph nodes associated with several different 
types of ovarian tumors. Because of the poten-
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tial diagnostic problems associated with this 
finding, we provided a detailed description of 
clinicopathologic features and immunohisto-
chemical results of these cases. We also dis-
cussed a possible pathogenic mechanism for 
nodal mesothelial cell inclusions.
Materials and methods
Patients and tissue specimens
We reviewed all hematoxylin and eosin-stained 
slides obtained from pelvic and para-aortic 
lymph node dissection specimens at the 
Samsung Medical Center (Seoul, Republic of 
Korea) from January 2009 to December 2014. 
Specimens with a final diagnosis of mesothelial 
cell inclusions in the pelvic and/or paraaortic 
lymph nodes were then selected for medical 
chart review. All specimens were reviewed by 
board-certified pathologists specializing in 
gynecologic pathology. The charts of these 
patients were reviewed for age, presenting 
symptoms, preoperative imaging findings, pri-
mary diagnosis, nodal status and follow-up 
data.
Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue bloc- 
ks were available for immunohistochemical 
staining in each case. Protein expression was 
Table 1. Clinical features of 10 cases with mesothelial cell inclusions in pelvic and para-aortic lymph 
nodes
Case Age/Sex Clinical presentation Primary diagnosis
Large-volu- 
me ascites Outcome
Follow-up 
(month)
1 52/F Adnexal mass Clear cell carcinoma of ovary Present NED 3
2 45/F Abdominal distension High-grade serous carcinoma of ovary Present AWD 38
3 75/F Adnexal mass High-grade serous carcinoma of ovary Present DOD 32
4 41/F Abdominal distension Struma ovarii Present NED 5
5 49/F Adnexal mass Proliferative struma ovarii Present NED 6
6 50/F Adnexal mass Proliferative struma ovarii Present NED 41
7 50/F Bilateral adnexal masses Serous borderline tumor of ovary Present NED 16
8 61/F Adnexal mass Mucinous carcinoma of ovary Present NED 53
9 50/F Bilateral adnexal masses Malignant Brenner tumor of ovary Present NED 5
10 52/F Bilateral adnexal masses Malignant Brenner tumor of ovary Present NED 2
NED indicates no evidence of disease; AWD, alive with disease; DOD, died of cancer-related disease.
Figure 1. Representative imaging findings of A. Case 1 and B. Case 5. Abdominopelvic computed tomographic scan 
reveal massive ascites and adnexal masses (white arrows).
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evaluated using a Ventana BenchMark XT auto-
mated staining system (Ventana Medical 
Systems, Inc., Tucson, AZ, USA) with antibodies 
against calretinin (1:80, clone 5A5, Novocastra, 
Newcastle upon Tyne, UK), pan-cytokeratin 
(CK; 1:500, clone AE1/AE3, Dako, Glostrup, 
Denmark), D2-40 (1:100, clone D2-40, Dako), 
WT-1 (1:50, clone 6F-H2, Dako), CD68 (1:2,000, 
clone KP-1, Dako), carcinoembryonic antigen 
(CEA; 1:4,000, polyclonal, Dako), epithelial 
membrane antigen (EMA; 1:300, clone E29, 
Dako), p53 (1:5,000, clone DO-7, Dako) and thy-
roid transcription factor (TTF-1; 1:100, clone 
8G7G3/1, Dako), according to the manufactur-
Figure 2. Histopathological findings. A. The mesothelial cells distend the subcapsular sinus. B. They form cuffs 
surrounding a lymphoid follicle. Both The C. Intra- and D. extranodal lymphatics contain mesothelial cells (black ar-
rows). E. Clusters of mesothelial cells with polygonal shape and eosinophilic cytoplasm expand the medullary sinus. 
These cells show round or oval nuclei with inconspicuous nucleoli and no significant nuclear atypia. F. The omentum 
displays florid mesothelial cell hyperplasia.
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Table 2. Histopathological and immunohistochemical findings of 10 cases with mesothelial cell inclusions in pelvic and para-aortic lymph nodes
Case
Histopathological findings
Immunostaining results
Location of involved lymph nodes Microanatomical Location Number of involved nodes Association With MCH
1 Pelvic, para-aortic SCS, TS, ENL 3/37 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-
2 Pelvic SCS, TS, MS, INL, ENL 6/82 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-/p53-
3 Pelvic SCS, TS, MS, ENL 4/20 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-/p53-
4 Pelvic SCS, TS, ENL 2/12 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-
5 Pelvic SCS, TS, MS, INL 3/11 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-/TTF-1-
6 Pelvic, para-aortic SCS, TS, MS, ENL 4/26 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-/TTF-1-
7 Pelvic, para-aortic SCS, TS, MS, ENL 5/17 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68--/CEA-/EMA-
8 Pelvic SCS, TS, ENL 4/11 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-
9 Pelvic, para-aortic SCS, TS, ENL 2/21 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-
10 Pelvic SCS, TS, INL, ENL 4/31 Yes Calretinin+/pan-CK+/D2-40+/WT-1+CD68-/CEA-/EMA-
SCS, subcapsular sinus; TS, trabecular sinus; ENL, extranodal lymphatics; INL, intranodal lymphatics; MS, medullary sinus; CK, cytokeratin; WT-1, Wilms tumor-1; CEA, carcinoembryonic antigen; EMA, epithelial 
membrane antigen; TTF-1, thyroid transcription factor-1.
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er’s protocol. Briefly, 4-μm tissue sections were 
deparaffinized and rehydrated, and antigens 
were retrieved for 40 min in a citrate buffer (pH 
6.1) at 95°C. 3,3’-diaminobenzidine was used 
as the chromogen, and the sections were coun-
terstained with hematoxylin.
Results
Clinical findings
The clinicopathologic features of 10 patients 
with mesothelial cell inclusions in pelvic and/or 
Figure 3. Immunohistochemical staining results. A. Calretinin intensely stains mesothelial cells within the subcap-
sular sinuses. B. Pan-CK highlights the presence of mesothelial cells that surround a lymphoid follicle. C. Pan-CK 
is strongly positive in the cytoplasm and membrane of mesothelial cells. D. Positive expression of D2-40 is also 
located in both the membrane and cytoplasm. E. The presence of mesothelial cells within extranodal lymphatics is 
confirmed by D2-40, which stains both lymphatic endothelial cells and mesothelial cells (black arrow). F. WT-1 im-
munostaining demonstrates uniform, strong nuclear expression in the mesothelial cells.
Nodal mesothelial cell inclusions
5323 Int J Clin Exp Pathol 2015;8(5):5318-5326
para-aortic lymph nodes were summarized in 
Table 1. The median age of patients was 50 
years (range, 41-75 years). Eight patients pre-
sented with unilateral or bilateral adnexal 
masses, and 2 patients complained primarily 
of abdominal distension. Six patients received 
surgery for malignant ovarian tumors, including 
clear cell carcinoma (n=1), high-grade serous 
carcinoma (n=2), mucinous carcinoma (n=1) 
and malignant Brenner tumor (n=2). Three 
patients had struma ovarii; tumors in 2 of these 
patients showing histologic features of follicu-
lar adenoma of the thyroid gland were diag-
nosed as proliferative struma ovarii [21]. One 
patient received surgery for serous borderline 
tumor. Preoperative imaging studies revealed 
massive ascites ranging from 4-6 L in all cases. 
Representative computed tomographic scan 
findings were shown in Figure 1. Pelvic and/or 
para-aortic lymphadenectomy was performed 
in all cases. The median number of dissected 
lymph nodes was 20 (range, 11-82). 
Pathologic findings
Grossly, the appearance of dissected lymph 
nodes was unremarkable, hence a minimal 
gross description of the involved lymph nodes 
was provided. The greatest dimension of the 
involved lymph node ranged from 0.2 cm to 3.2 
cm. In 4 cases (Cases 2, 3, 8 and 9), pelvic 
lymph nodes harbored both metastatic tumor 
cells and mesothelial cells. In the remaining 
cases, non-tumorous lymph nodes contained 
mesothelial cells.
Microscopically, all cases had clusters of meso-
thelial cells confined to nodal sinuses. The 
median number of involved lymph nodes was 4 
(range, 2-6). These were most prominent in the 
supcapsular and trabecular sinuses (Figure 
2A), but in 5 cases they also packed the medul-
lary sinuses. The sinuses containing mesothe-
lial cells were more expanded than neighboring 
sinuses that contained histiocytes only. Some 
of these mesothelial cells formed cuffs sur-
rounding lymphoid follicles (Figure 2B). 
Occasionally, cohesive nests or individual cells 
were identified within the lumina of dilated 
intranodal lymphatics (Figure 2C) or within lym-
phatics in the extranodal adipose tissue (Figure 
2D). Cytologically, the mesothelial cells were 
polygonal, with abundant eosinophilic cyto-
plasm and bland vesicular nuclei (Figure 2E). 
Mesothelial cells were difficult to distinguish 
from sinus histiocytes due to their relatively 
indistinct cell borders, together with bland 
nuclear features. Mesothelial cells, however, 
exhibited a greater degree of cohesiveness, 
larger size, more eosinophilic cytoplasm, slight-
ly better demarcated cell borders, epithelioid 
appearance and prominent nucleoli. Metastatic 
carcinoma was ruled out based on absence of 
significant nuclear atypia or hyperchromasia 
and condensed chromatin.
The outcome of patients was also summarized 
in Table 1. The median follow-up time was 15 
months (range, 2-52). Eight patients are cur-
rently without evidence of disease after follow-
up. One patient is alive with stable disease, and 
the remaining patient died of ovarian cancer. 
No patients developed complications or recur-
rent lesions associated with nodal mesothelial 
cell inclusions.
A summary of the immunohistochemical stain-
ing results was listed in Table 2. The findings 
clearly supported the mesothelial phenotype in 
each case. The mesothelial cells were strongly 
positive for calretinin (Figure 3A). Pan-CK 
immunostaining showed a membranous and 
cytoplasmic staining pattern (Figure 3B, 3C). 
The distinction between intranodal mesothelial 
cells and histiocytes was facilitated by the pan-
CK staining, which highlighted the presence of 
the strongly reactive mesothelial cells, in con-
trast to the nonreactive histiocytes. Positive 
expression of D2-40 was also located in both 
the membrane and cytoplasm (Figure 3D, 3E). 
D2-40, which stains both the lymphatic endo-
thelial cells and mesothelial cells, confirmed 
the presence of mesothelial cells within the 
extranodal lymphatics. WT-1 immunostaining 
revealed uniform, strong nuclear expression in 
the mesothelial cells (Figure 3F). The immunos-
tained slides showed greater mesothalial cell 
involvement than could be detected on the 
hematoxylin and eosin-stained slides. The 
mesothelial cells were negative for CD68, CEA 
and EMA (in all cases) and p53 (in 2 cases). In 
addition, the absence of TTF-1 expression 
excluded the possibility of metastatic follicular 
carcinoma in two patients with proliferative 
struma ovarii.
In 4 cases with malignant ovarian tumors 
(Cases 2, 3, 8 and 9), biopsy samples of the 
pelvic peritoneum and omentum revealed both 
metastatic tumor and mesothelial cell hyper-
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plasia. The other peritoneal biopsy specimens 
and omentum also showed a variable degree of 
inflammatory reaction and mesothelial cell 
hyperplasia (Figure 2F). Additionally, 2 cases 
had foci of endosalpingiosis within pelvic lymph 
nodes. In another case, 2 para-aortic lymph 
nodes contained ectopic decidua and decidual-
ized intranodal endometriosis, respectively.
Discussion
This report documented the presence of meso-
thelial cells within pelvic and paraaortic lymph 
nodes that were removed as part of staging 
laparotomy in 10 women with ovarian tumors. 
In each case, we found massive ascites and 
hyperplasia of the peritoneal mesothelial cells, 
a common finding in patients with ovarian 
tumors. To the best of our knowledge, this is 
the largest single-center cohort of patients with 
nodal mesothelial cell inclusions occurring in 
association with massive ascites.
Benign mesothelial cells that involve the sinus-
es of mediastinal lymph nodes were originally 
described by Brooks et al. in 1990 [6]. They 
described mesothelial cell inclusions in 2 
patients with pleuritis and pleural effusions. 
Rutty and Lauder reported another case of 
mesothelial cell inclusions within mediastinal 
lymph nodes, associated with both pleural and 
pericardial effusion [18]. In addition, mesothe-
lial cell inclusions were reported in cervical, 
mediastinal, abdominal and pelvic lymph node 
sinuses [7, 13, 20, 22]. Most of these cases 
had concurrent serosal effusions. Nodal meso-
thelial cells are thought to originate from meso-
thelial surfaces disrupted by serosal effusions 
[11]. It is believed that mesothelial cell inclu-
sions represent migration from the pleural or 
peritoneal cavity through preformed stomata 
that are located within the pleura or peritone-
um [6, 23]. Lymphatic transport of dislodged 
mesothelial cells is the likely pathogenic mech-
anism for nodal mesothelial cell inclusions [6, 
7, 18]. Peritoneal and pleural stomata were 
confirmed in animal studies [23]. These stoma-
ta link the peritoneal cavity with submesotheli-
al lymphatics. Peritoneal inflammation and 
mesothelial reactions disrupt mesothelial sto-
mata and distend lymphatics, allowing meso-
thelial cells to access submesothelial lymphat-
ics and enter and drain into the nodal sinuses 
[6, 7, 18]. Their entry could be facilitated by the 
pressure gradient, secondary to massive asci-
tes. The proposed pathogenesis was supported 
by the significant association of pleural, peri-
cardial and peritoneal effusions with mesothe-
lial cells in nodal sinuses [5-7, 9, 11, 12, 14, 16, 
18-20, 22]. Consistent with previous data, it is 
possible that massive ascites present in this 
study led to distension of intraperitoneal lym-
phatics, allowing access of mesothelial cells to 
pelvic lymph node sinuses. 
In addition to mesothelial cells in the nodal 
sinuses, there were mesothelial cell clusters 
within both intra- and extranodal lymphatics. 
The extranodal lymphatic permeation by meso-
thelial cells is confirmatory evidence of their 
lymphatic transport and strongly supports the 
lymphatic transport theory of pathogenesis of 
mesothelial cell inclusions within lymph nodes. 
To the best of our knowledge, there have been 
3 previous reports of extranodal lymphatic 
involvement by mesothelial cells in the pres-
ence of nodal inclusions [7, 12].
Often mesothelial cell inclusions can present a 
diagnostic dilemma to the pathologist. The 
most important differential diagnosis of nong-
landular nodal inclusions includes metastatic 
carcinoma and benign mesothelial cell inclu-
sions. It is important not to misdiagnose meso-
thelial cells within pelvic lymph nodes as meta-
static carcinoma, since this error could result in 
incorrect staging and overtreatment of patients 
with known intra-abdominal or pelvic malignant 
tumors or false negative diagnosis of occult pri-
mary tumors in patients without obvious tumor. 
Isotalo et al. [12] described a patient who 
received radiotherapy on misdiagnosis of 
mesothelial cells within the mediastinal lymph 
node sinuses as metastatic carcinoma. Benign 
mesothelial cell inclusions involve exclusively 
nodal sinuses and do not infiltrate the nodal 
parenchyma. Metastatic carcinoma, unlike 
benign inclusions, may demonstrate glandular 
differentiation and infiltration of the nodal cap-
sule or cortex. The exclusively sinusoidal 
involvement and the characteristic appearance 
of the mesothelial cells including their bland 
nuclear features differentiate them from meta-
static carcinoma. Furthermore, sinus mesothe-
lial cells may also be confused with sinus histio-
cytes, metastatic melanoma and metastatic 
mesothelioma [6, 7, 22]. The benign histologic 
appearance of mesothelial cells and their 
unique immunophenotype are important identi-
fying features [6, 7, 22]. Sinus histiocytosis 
Nodal mesothelial cell inclusions
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shows a proliferation of large histiocytes with 
abundant cytoplasm and bland nuclear fea-
tures within the sinuses. The lack of nuclear 
atypia, positivity for CD68 and negativity for 
epithelial and mesothelial cell markers con-
firms the histiocytic origin. The majority of met-
astatic melanoma has an antecedent history of 
primary malignant melanoma on the skin or 
mucous membrane. Morphological diversity 
and/or lipofuscin granules can be seen in the 
cytoplasm. Melanoma cells exhibit diffuse posi-
tivity for S-100 protein, as well as positivity for 
melanocytic markers including HMB45 and 
melan-A. Malignant mesothelioma often pres-
ents a definite primary lesion, i.e., multiple, dis-
crete, irregular nodules on the serosal surface. 
The patient usually has an obvious tumor mass. 
A high-grade nuclear atypia, formation of micro-
tubules, tubulopapillary and alveolar patterns, 
destructive stromal infiltrates and sclerosis 
favor a diagnosis of malignant mesothelioma 
[7].
In summary, we demonstrated benign meso-
thelial cell inclusions in pelvic and para-aortic 
lymph nodes in patients with different types of 
ovarian tumors. In general, they consist of 
bland-appearing polygonal cells in the subcap-
sular and trabecular sinuses that are most like-
ly overlooked or misinterpreted as histiocytes. 
Rarely, these cells are numerous and are sus-
pected as metastatic carcinoma, melanoma or 
mesothelioma. The distinction from metastatic 
tumors is based on the exclusively sinusoidal 
pattern of involvement, bland nuclear features 
and immunophenotype. Mesothelial cell inclu-
sions are likely to result from the dislodgement 
and subsequent lymphatic transport in the 
presence of serosal effusions. Even though 
these inclusions are benign, their identification 
may cause a diagnostic problem. Awareness of 
these mesothelial cells, their location and their 
similarity with malignant neoplasms, is crucial 
in preventing both misdiagnosis and the inap-
propriate therapeutic management of patients.
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